4.4 Article

Guidelines for the communication of Biomonitoring Equivalents: Report from the Biomonitoring Equivalents Expert Workshop

期刊

REGULATORY TOXICOLOGY AND PHARMACOLOGY
卷 51, 期 3, 页码 S16-S26

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yrtph.2008.05.007

关键词

biomonitoring; Biomonitoring Equivalents; risk communication; BEs; transparency; exposure guidance values

向作者/读者索取更多资源

Biomonitoring Equivalents (BEs) are screening tools for interpreting biomonitoring data. However, the development of BEs brings to the public a relatively novel concept in the field of health risk assessment and presents new challenges for environmental risk communication. This paper provides guidance on methods for conveying information to the general public, the health care community, regulators and other interested parties regarding how chemical-specific BEs are derived, what they mean in terms of health, and the challenges and questions related to interpretation and communication of biomonitoring data. Key communication issues include: (i) developing a definition of the BE that accurately captures the BE concept in lay terms, (ii) how to compare population biomonitoring data to BEs, (iii) interpreting biomonitoring data that exceed BEs for a specific chemical, (iv) how to best describe the confidence in chemical-specific BEs, and (v) key requirements for effective communication with health care professionals. While the risk communication literature specific to biomonitoring is sparse, many of the concepts developed for traditional risk assessments apply, including transparency and discussions of confidence and uncertainty. Communication of BEs will require outreach, education, and development of communication materials specific to several audiences including the lay public and health care providers. (c) 2008 Elsevier Inc, All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Toxicology

Derivation of an occupational exposure limit for benzene using epidemiological study quality assessment tools

A. Robert Schnatter, Martijn Rooseboom, Neslihan Aygun Kocabas, Colin M. North, Abigail Dalzell, Johannes Twisk, Frank Faulhammer, Erik Rushton, Peter J. Boogaard, Viktorija Ostapenkaite, Stephen D. Williams

TOXICOLOGY LETTERS (2020)

Article Health Care Sciences & Services

GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making

Jan L. Brozek, Carlos Canelo-Aybar, Elie A. Akl, James M. Bowen, John Bucher, Weihsueh A. Chiu, Mark Cronin, Benjamin Djulbegovic, Maicon Falavigna, Gordon H. Guyatt, Ami A. Gordon, Michele Hilton Boon, Raymond C. W. Hutubessy, Manuela A. Joore, Vittal Katikireddi, Judy LaKind, Miranda Langendam, Veena Manja, Kristen Magnuson, Alexander G. Mathioudakis, Joerg Meerpohl, Dominik Mertz, Roman Mezencev, Rebecca Morgan, Gian Paolo Morgano, Reem Mustafa, Martin O'Flaherty, Grace Patlewicz, John J. Riva, Margarita Posso, Andrew Rooney, Paul M. Schlosser, Lisa Schwartz, Ian Shemilt, Jean-Eric Tarride, Kristina A. Thayer, Katya Tsaioun, Luke Vale, John Wambaugh, Jessica Wignall, Ashley Williams, Feng Xie, Yuan Zhang, Holger J. Schunemann

Summary: This study presents a conceptual approach for evaluating the certainty of evidence from modeling studies using the GRADE method. The results indicate that the domains determining the certainty of evidence also apply to assessing evidence from models. A framework for selecting the best evidence from models and a summary of preferred terminology are proposed to facilitate communication between modeling and health care disciplines.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)

Article Reproductive Biology

Prenatal developmental toxicity studies on fumes from oxidised asphalt (OA) in the rat

Peter J. Boogaard, Jochen Buschmann, Rainer Fuhst, Katharina Bluemlein, Wolfgang Koch, Dirk Schaudien, Katharina Schwarz, Christine McAlinden, Lize Deferme, Mathieu Vaissiere, Hans B. Ketelslegers, Anna Steneholm

Summary: Rats exposed to fumes of oxidised asphalt did not show prenatal developmental toxicity, however, high-dose exposure resulted in effects on maternal body weight gain, food consumption, lung weights, and histopathological changes in lungs and the upper respiratory tract.

REPRODUCTIVE TOXICOLOGY (2021)

Article Medicine, Legal

Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment

Yu-Mei Tan, Hugh A. Barton, Alan Boobis, Rachel Brunner, Harvey Clewell, Rhian Cope, Jeffrey Dawson, Jeanne Domoradzki, Peter Egeghy, Pankaj Gulati, Brandall Ingle, Nicole Kleinstreuer, Kelly Lowe, Anna Lowit, Elizabeth Mendez, David Miller, Jeffrey Minucci, James Nguyen, Alicia Paini, Monique Perron, Katherine Phillips, Hua Qian, Tharacad Ramanarayanan, Fiona Sewell, Philip Villanueva, John Wambaugh, Michelle Embry

Summary: In repeated dose animal studies, there are various methods for dose selection, including identification of apical endpoints, use of the limit dose, and determination of a maximum tolerated dose. An alternative approach, the kinetically derived maximum dose, integrates toxicokinetic data into the dose selection process as a mechanism.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2021)

Article Environmental Sciences

Current Breast Milk PFAS Levels in the United States and Canada: After All This Time, Why Don't We Know More?

Judy S. LaKind, Marc-Andre Verner, Rachel D. Rogers, Helen Goeden, Daniel Q. Naiman, Satori A. Marchitti, Geniece M. Lehmann, Erin P. Hines, Suzanne E. Fenton

Summary: Despite 20 years of biomonitoring studies of PFAS in serum and urine, there is limited understanding of PFAS concentrations in breast milk of women from the United States and Canada. More research is needed to evaluate the potential impact on infant and family health.

ENVIRONMENTAL HEALTH PERSPECTIVES (2022)

Review Environmental Sciences

Elements to increase translation in pyrethroid epidemiology research: A review

Carol J. Burns, Judy S. LaKind

Summary: This study reviewed the epidemiology literature on pyrethroid insecticides and evaluated the methodological elements for their relevance in risk assessment and decision-making. The results showed that only a small portion of the studies met the requirements for risk assessment, indicating the opportunity for future research to incorporate more translational approaches.

SCIENCE OF THE TOTAL ENVIRONMENT (2022)

Review Biochemistry & Molecular Biology

Metallothionein and Cadmium Toxicology-Historical Review and Commentary

Monica Nordberg, Gunnar F. Nordberg

Summary: This review summarizes the adverse effects of cadmium on human and animal health and emphasizes the importance of preventive measures. It specifically focuses on the role of metallothionein (MT) in cadmium toxicology and highlights the binding of cadmium to MT and the importance of the Cd/Zn ratio in kidney toxicity. The review calls for the application of these findings in risk assessment and preventive measures against cadmium exposures.

BIOMOLECULES (2022)

Article Environmental Sciences

Research on COVID-19 and air pollution: A path towards advancing exposure science

Carol J. Burns, Judy S. LaKind, Josh Naiman, Denali Boon, Jane E. Clougherty, Ana M. Rule, Angelika Zidek

Summary: The COVID-19 pandemic has highlighted the need for research on factors that can reduce health risks, especially modifiable factors. Numerous studies have been conducted on the complex relationships between SARS-CoV2 transmission, air pollution, and human health, but they are limited by available data. This project aimed to gather input on improving and funding exposure research on the confluence of air pollution and infectious agents. Experts from various fields provided valuable insights, emphasizing the importance of common definitions, source-specific research, and improved study design. Further discussions are needed to advance our understanding and prepare for future pandemics.

ENVIRONMENTAL RESEARCH (2022)

Review Environmental Sciences

Per- and polyfluoroalkyl substances (PFAS) in breast milk and infant formula: A global issue

Judy S. LaKind, Josh Naiman, Marc-Andre Verner, Laura Leveque, Suzanne Fenton

Summary: This study compares global breast milk and infant formula PFAS measurements with children's drinking water screening values. It finds that concentrations of PFOA and PFOS in breast milk often exceed these values, regardless of geographic location. This highlights the importance of providing pregnant and lactating women, especially those from PFAS-contaminated communities, with the necessary data to make informed decisions on infant nutrition.

ENVIRONMENTAL RESEARCH (2023)

Article Public, Environmental & Occupational Health

Interpreting biomonitoring data: Introducing the international human biomonitoring (i-HBM) working group's health-based guidance value (HB2GV) dashboard

Shoji F. Nakayama, Annie St-Amand, Tyler Pollock, Petra Apel, Yu Ait Bamai, Dana Boyd Barr, Jos Bessems, Antonia M. Calafat, Argelia Castano, Adrian Covaci, Radu Corneliu Duca, Sarah Faure, Karen S. Galea, Sean Hays, Nancy B. Hopf, Yuki Ito, Maryam Zare Jeddi, Marike Kolossa-Gehring, Eva Kumar, Judy S. LaKind, Marta Esteban Lopez, Henriqueta Louro, Kristin Macey, Konstantinos C. Makris, Lisa Melnyk, Aline Murawski, Josh Naiman, Julianne Nassif, Nolwenn Noisel, Devika Poddalgoda, Lesliam Quiros-Alcala, Ata Rafiee, Loic Rambaud, Maria Joao Silva, Jun Ueyama, Marc-Andre Verner, Maisarah Nasution Waras, Kate Werry

Summary: Human biomonitoring (HBM) data can be used to compare population exposures, but finding the relevant health-based biomonitoring guidance values can be time-consuming. To address this issue, an online repository called the Human Biomonitoring Health-Based Guidance Value (HB2GV) Dashboard has been created. This database provides a centralized location for researchers and decision makers to access and interpret HBM data.

INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2023)

Article Environmental Sciences

A Novel Application of Risk-Risk Tradeoffs in Occupational Health: Nurses' Occupational Asthma and Infection Risk Perceptions Related to Cleaning and Disinfection during COVID-19

Amanda M. Wilson, Irene Mussio, Susan Chilton, Lynn B. Gerald, Rachael M. Jones, Frank A. Drews, Judy S. LaKind, Paloma I. Beamer

Summary: Using an online survey, this study examined nurses' risk preferences and found that most nurses were willing to increase infection risk to maintain baseline occupational asthma (OA) risk, but not willing to accept a larger risk of death to avoid doubling their OA risk. Age, work experience, and previous experience with respiratory viral infections influenced the nurses' choices.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Editorial Material Environmental Sciences

Invited Perspective: PFAS in Breast Milk and Infant Formula-It's Time to Start Monitoring

Judy S. LaKind

Summary: The study by Yao et al. provides valuable insights into infant exposures to per- and polyfluoroalkyl substances (PFAS). They emphasize the importance of establishing a national baseline of PFAS exposure in human milk and assessing the risks of PFAS exposure in exclusively breastfed infants. Despite the existence of national programs for assessing human exposures to environmental chemicals, efforts focused on breast milk monitoring are lacking.

ENVIRONMENTAL HEALTH PERSPECTIVES (2023)

Review Toxicology

Human biomonitoring of low-level benzene exposures

Peter J. Boogaard

Summary: Benzene is a toxic substance that can cause acute and chronic health effects, including blood disorders and leukemia. Occupational exposure limits (OELs) have been continuously lowered to protect workers from benzene-induced cancer. Human biomonitoring using various potential biomarkers in urine and blood samples is commonly used to assess exposure to benzene.

CRITICAL REVIEWS IN TOXICOLOGY (2022)

Review Toxicology

Using the Matrix to bridge the epidemiology/risk assessment gap: a case study of 2,4-D

Carol J. Burns, Judy S. LaKind

Summary: The study highlights the importance of the Matrix in facilitating discussions between risk assessment and epidemiology, providing insights on the elements of risk assessment that need to be considered in epidemiology research. Recommendations for improving study design and translation of results are proposed to bridge the gap between epidemiology and risk assessment.

CRITICAL REVIEWS IN TOXICOLOGY (2021)

Review Toxicology

Does ozone inhalation cause adverse metabolic effects in humans? A systematic review

Judy S. LaKind, Carol J. Burns, Lynn H. Pottenger, Daniel Q. Naiman, Julie E. Goodman, Satori A. Marchitti

Summary: The study applied a transparent approach to systematically review the evidence on ozone inhalation exposure and adverse metabolic effects. The evidence for the health outcomes assessed was generally weak, with some indications lacking or suggestive details, but overall lacking strong evidence support.

CRITICAL REVIEWS IN TOXICOLOGY (2021)

Article Medicine, Legal

New supporting data to guide the use of evident toxicity in acute oral toxicity studies (OECD TG 420)

Fiona Sewell, Ian Ragan, Graham Horgan, David Andrew, Thomas Holmes, Irene Manou, Boris P. Mueller, Tim Rowan, Barbara G. Schmitt, Marco Corvaro

Summary: There are currently three test guidelines for acute oral toxicity studies, but the subjectivity of one guideline may be hindering its wider use. In order to address this, the NC3Rs and EPAA collaborated to analyze historical data and provide recommendations on the recognition of 'evident toxicity'.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2024)

Article Medicine, Legal

The 2022 world health organization reevaluation of human and mammalian toxic equivalency factors for polychlorinated dioxins, dibenzofurans and biphenyls

Michael DeVito, Bas Bokkers, Majorie B. M. van Duursen, Karin van Ede, Mark Feeley, Elsa Antunes Fernandes Gaspar, Laurie Haws, Sean Kennedy, Richard E. Peterson, Ron Hoogenboom, Keiko Nohara, Kim Petersen, Cynthia Rider, Martin Rose, Stephen Safe, Dieter Schrenk, Matthew W. Wheeler, Daniele S. Wikoff, Bin Zhao, Martin van den Berg

Summary: In October 2022, the World Health Organization reevaluated the toxic equivalency factors (TEFs) for chlorinated dioxin-like compounds in a panel convened in Lisbon. This effort utilized an updated database, Bayesian dose response modeling, and meta-analysis to derive Best-Estimate TEFs. Applying these new TEFs may result in lower total toxic equivalents for dioxin-like chemicals.

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2024)